Pearim Pharmaceuticals Private Limited
About Pearim Pharmaceuticals Private Limited
Data last updated:
Pearim Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 September 1980 and has been in existence for over 46 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24200MH1980PTC023204. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹7.5 Lakh. It is led by directors including Meena Balvant Desai and Vidyut Dilip Shah.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 30 Sheila Apartment2 Bhulabhai Desai Rd, Mumbai, Maharashtra, India – 400026.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.06 Lakh, a decline of 3% compared to the previous year. For the same year it recorded a net loss of ₹85,281 (net margin -41.5%) and EBITDA of -₹85,133 (EBITDA margin -41.4%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 1% over five years.
Court records list 10 cases involving the company, including 10 filed against it; 3 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Pearim Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address30 Sheila Apartment2 Bhulabhai Desai Rd, Mumbai, Maharashtra, India – 400026
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Pearim Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Pearim Pharmaceuticals Private Limited
FY 2024 filings availablePearim Pharmaceuticals Private Limited reported revenue of ₹2.06 Lakh (down 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 3% fall in the latest year. EBITDA rose 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹85,133 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹85,281 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -41.4% | ||||
| Net Profit Margin | -41.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pearim Pharmaceuticals Private Limited, buy the company report.
Board of directors of Pearim Pharmaceuticals Private Limited
Pearim Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Meena Balvant Desai | Director | 01 Aug 2018 | 8 Years 3 Months | Current |
| Vidyut Dilip Shah Also directs: Alvaetra Laboratories Pvt Ltd, Ray Property Developers Private Limited, Saurabh Desai Exports Private Limited and 1 more | Director | 12 Jun 2014 | 12 Years 5 Months | Current |
| Radhika Vidyut Shah Also directs: Alvaetra Laboratories Pvt Ltd, Saurabh Desai Exports Private Limited, V S International Private Limited and 1 more | Director | 25 Apr 2018 | 8 Years 6 Months | Current |
Auditor
Pearim Pharmaceuticals Private Limited is audited by KHANDWALA & SHAH for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KHANDWALA & SHAH | FY 2023 | 105069W |
Shareholding
The shareholding of Pearim Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Pearim Pharmaceuticals Private Limited, buy the company report.
Legal cases
Pearim Pharmaceuticals Private Limited has 10 court cases on record: 10 filed against it. 3 cases are pending and 7 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 10 | 10 | 3 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Interim or miscellaneous application | Filed against the company | Pending |
| Bombay High Court | Court case (S) | Filed against the company | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed against the company | Disposed |
| Bombay High Court | Court case (CHS) | Filed against the company | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed against the company | Disposed |
To see the full case history of Pearim Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pearim Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Pearim Pharmaceuticals has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Pearim Pharmaceuticals Private Limited, buy the company report.
Recent activity
Pearim Pharmaceuticals Private Limited has 6 board changes on record since 2007: 3 appointments and 3 cessations. The latest: Meena Balvant Desai was appointed as Director on 01 Aug 2018.
Frequently asked questions
Pearim Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 September 1980 (46+ years old) and is registered under CIN U24200MH1980PTC023204.
Pearim Pharmaceuticals has 3 current directors:
- Meena Balvant Desai - Director
- Vidyut Dilip Shah - Director
- Radhika Vidyut Shah - Director
The latest financial statements of Pearim Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
No. Pearim Pharmaceuticals has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Pearim Pharmaceuticals is U24200MH1980PTC023204. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pearim Pharmaceuticals has 10 court cases on record: 10 filed against it. 3 are pending.
Pearim Pharmaceuticals was incorporated on 25 September 1980, making it 46+ years old. It is registered with the Registrar of Companies, Mumbai.
Meena Balvant Desai was appointed as Director on 01 Aug 2018. Chandulal Pitambardas Shah ceased to be Director on 26 Jul 2018. Radhika Vidyut Shah was appointed as Director on 25 Apr 2018. Pearim Pharmaceuticals has 6 board changes on record in total.
The registered office of Pearim Pharmaceuticals is at 30 Sheila Apartment2 Bhulabhai Desai Rd, Mumbai, Maharashtra, India – 400026.
Pearim Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
